You just read:

Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to receive positive opinion from EMA's CHMP for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis

News provided by

Hospira, Inc.

28 Jun, 2013, 12:54 BST